Nerve Growth Factor Levels in Cerebrospinal Fluid From Patients With Neurologic Disorders

Abstract

Nerve growth factor levels were measured in the cerebrospinal fluid from 73 patients with neurologic disorders and non-neurologic acute illnesses by a two-site enzyme immunoassay. Elevated nerve growth factor levels in cerebrospinal fluid were demonstrated in 2 of 7 patients with bacterial meningitis, 7 of 14 patients with viral meningitis or encephalitis, and 1 with multiple sclerosis. Follow-up examinations of the 3 patients (1 with bacterial meningitis, 1 with viral meningitis, and 1 with multiple sclerosis) at convalescent stage showed diminished nerve growth factor levels in cerebrospinal fluid. None of the other patients showed elevation of nerve growth factor levels in cerebrospinal fluid. Nerve growth factor levels in cerebrospinal fluid were not correlated with cell numbers in patients with meningitis or encephalitis. No relationship was observed between nerve growth factor levels and outcome in patients with viral meningitis or encephalitis and bacterial meningitis. Nerve growth factor in cerebrospinal fluid may play a role in neuronal recovery or function as an immunomodulator in children with inflammatory and immune-mediated neurologic disorders. (J Child Neurol 1997; 12:205-207).

Get full access to this article

View all access options for this article.

References

Levi-Montalcini R. , Aloe L. , Alleva E. : A role for nerve growth factor in nervous, endocrine, and immune system. Prog Neuro Endocrinol Immunol 1990; 3: 1-10.

Patterson SL , Grady MS , Bothwell M. : Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res 1993;605:43-49.

Laudiero LB , Aioe L. , Levi-Montalcini R. , et al: Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992;147:9-22.

Hashimoto Y. , Omae F. , Furukawa S. : Reduction of nerve growth factor protein level in rat dorsal hippocampus following administration of kainic acid. Neurosci Lett 1992;140:203-205.

Gradient RA , Cron KC , Otten U. : Interleukin- 1β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 1990;117: 335-340.

Hattori A. , Iwasaki S. , Murase K. , et al: Tumor necrosis factor is markedly synergistic with interleukin-1 and interferon-γ in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994;340:177-180.

Santambrogio L. , Benecletti M. , Chao MV , et al: Nerve growth factor production by lymphocytes. J Immuraol 1994;153:4488-4495.

Frei K. , Malipiero UV , Leist TP , et al: On the cellular source and function of interleukin 6 produced in the central nervous system in viral disease. Eur J Immunol 1989;19:689-694.

Quagliarello V. , Scheld WM : Bacterial meningitis: Pathogenesis, pathophysiology, and progress. N Engl J Med 1992;327:864-872.

10.

Frei K. , Leist TP , Meager A. , et al: Production of B cell stimulating factor-2 and interferon-γ in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med 1988;168:449-453.

11.

Ramilo O. , Mustafa MM , Porter J. , et al: Detection of interleukin 1 but not tumor necrosis factor-α in cerebrospinal fluid of children with aseptic meningitis. Am J Dis Child 1990;144:349-353.

12.

Maimone D. , Gregory S. , Arnason BGW , et al: Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 1991 ;32:67-74.

13.

Otten U. , Ehrhard P. , Peck R. : Nerve growth factor induces growth and differentiation of human B lymphocytes . Proc Natl Acad Sci USA 1989;86:10059-10063.

14.

Raine CS : The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 1994;36 (Suppl): 61-72.

15.

Arditi M. , Manogue KR , Caplan M. , et al: Cerebrospinal fluid cachectin/tumor necrosis factor-α and severity of bacterial meningitis in children. J Infect Dis 1990;162:139-147.